SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031995
Filing Date
2024-08-14
Accepted
2024-08-14 12:00:34
Documents
75
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1466364
2 ex31-1.htm EX-31.1 21088
3 ex31-2.htm EX-31.2 21092
4 ex32-1.htm EX-32.1 7359
5 ex32-2.htm EX-32.2 7363
  Complete submission text file 0001493152-24-031995.txt   7854278

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20240630.xsd EX-101.SCH 62312
7 XBRL CALCULATION FILE otlc-20240630_cal.xml EX-101.CAL 47250
8 XBRL DEFINITION FILE otlc-20240630_def.xml EX-101.DEF 304837
9 XBRL LABEL FILE otlc-20240630_lab.xml EX-101.LAB 435166
10 XBRL PRESENTATION FILE otlc-20240630_pre.xml EX-101.PRE 378604
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1271334
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 241205663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)